Replies to post #56410 on $heff's $tation of $tocks & $olid DD

[$heff]

NAVB..$4.31 Exactly..lack of Adv Panel signals that the FDA does not have further questions with regards to safety or efficacy of Lymphoseek. The company received the 90 day delay and at that point the FDA could have requested a panel for more clarity & they didn't. Bodes well for the company IMO.

[beach_trades]

INO.51 Looking for 200 day

http://stockcharts.com/h-sc/ui?s=ino

[jas2mel]

TLON 1.27 on watch here for a add